But instead of simply marketing Prozac to women with PMDD, Lilly has decided to launch fluoxetinehydrochloride, the chemical formerly known only as Prozac, as a brand-new drug called Sarafem.
The patent on the fluoxetinehydrochloride, the compound formerly known only as Prozac, runs out next year, and the patent on the process used to make it runs out in 2003.